Australian Capital Territory
Supervised Injecting Place Trial
Act 1999
A1999-90
Republication No 10
Effective: 1 September 2016
Republication date: 1 September 2016
Last amendment made by A2016-52
Authorised by the ACT Parliamentary Counsel
Authorised by the ACT Parliamentary Counsel—also accessible at www.legislation.act.gov.au
About this republication
The republished law
This is a republication of the Supervised Injecting Place Trial Act 1999 (including any
amendment made under the Legislation Act 2001, part 11.3 (Editorial changes)) as in force on
1 September 2016. It also includes any commencement, amendment, repeal or expiry affecting
this republished law to 1 September 2016.
The legislation history and amendment history of the republished law are set out in endnotes 3
and 4.
Kinds of republications
The Parliamentary Counsel’s Office prepares 2 kinds of republications of ACT laws (see the
ACT legislation register at www.legislation.act.gov.au):
• authorised republications to which the Legislation Act 2001 applies
• unauthorised republications.
The status of this republication appears on the bottom of each page.
Editorial changes
The Legislation Act 2001, part 11.3 authorises the Parliamentary Counsel to make editorial
amendments and other changes of a formal nature when preparing a law for republication.
Editorial changes do not change the effect of the law, but have effect as if they had been made
by an Act commencing on the republication date (see Legislation Act 2001, s 115 and s 117).
The changes are made if the Parliamentary Counsel considers they are desirable to bring the law
into line, or more closely into line, with current legislative drafting practice.
This republication does not include amendments made under part 11.3 (see endnote 1).
Uncommenced provisions and amendments
If a provision of the republished law has not commenced, the symbol U appears immediately
before the provision heading. Any uncommenced amendments that affect this republished law
are accessible on the ACT legislation register (www.legislation.act.gov.au). For more
information, see the home page for this law on the register.
Modifications
If a provision of the republished law is affected by a current modification, the symbol M
appears immediately before the provision heading. The text of the modifying provision appears
in the endnotes. For the legal status of modifications, see the Legislation Act 2001, section 95.
Penalties
At the republication date, the value of a penalty unit for an offence against this law is $150 for
an individual and $750 for a corporation (see Legislation Act 2001, s 133).
R10
01/09/16
Supervised Injecting Place Trial Act 1999
Effective: 01/09/16
contents 1
Authorised by the ACT Parliamentary Counsel—also accessible at
Australian Capital Territory
Supervised Injecting Place Trial
Act 1999
Contents
Page
Part 1 Introductory
1 Name of Act 2
2 Dictionary 2
3 Notes 2
4 Object 2
Part 2 Operation of facility
5 Declaration of facility 3
6 Declaration of operators 4
7 Law enforcement protocol 4
8 Publication of law enforcement protocol 4
9 Approval of internal management protocol 5
10 Criteria for assessing facility 6
Contents
Page
contents 2 Supervised Injecting Place Trial Act 1999
Effective: 01/09/16
R10
01/09/16
Authorised by the ACT Parliamentary Counsel—also accessible at www.legislation.act.gov.au
11 Exemption of staff and other persons from certain criminal
proceedings 7
12 Exemption of persons from certain civil proceedings 8
13 Directions to DPP 8
14 Things not permitted by Act 8
15 Provision of injecting equipment at facility 9
16 Provision of information about facility 9
17 Excluding persons from facility 10
Part 3 Advisory committee
18 Advisory committee 11
19 Committee’s functions 11
20 Constitution 11
21 Chairperson and deputy chairperson 13
22 Ending of appointments 13
24 Convening meetings 13
25 Leave of absence 14
26 Procedure 14
27 Quorum 14
28 Administration 14
Part 4 Consultation with committee
29 Minister must consult committee 15
30 Criteria for deciding place for facility 15
31 Review of the operation of scientific trial 16
Part 5 Miscellaneous
32 Regulation-making power 17
33 Expiry of Act 17
Dictionary 18
Endnotes
1 About the endnotes 20
Contents
Page
R10
01/09/16
Supervised Injecting Place Trial Act 1999
Effective: 01/09/16
contents 3
Authorised by the ACT Parliamentary Counsel—also accessible at www.legislation.act.gov.au
2 Abbreviation key 20
3 Legislation history 21
4 Amendment history 23
5 Earlier republications 25
R10
01/09/16
Supervised Injecting Place Trial Act 1999
Effective: 01/09/16
page 1
Authorised by the ACT Parliamentary Counsel—also accessible at www.legislation.act.gov.au
Australian Capital Territory
Supervised Injecting Place Trial
Act 1999
An Act to allow for a trial of a supervised injecting place for drug-dependent
people
Part 1 Introductory
Section 1
page 2 Supervised Injecting Place Trial Act 1999
Effective: 01/09/16
R10
01/09/16
Authorised by the ACT Parliamentary Counsel—also accessible at www.legislation.act.gov.au
Part 1 Introductory
1 Name of Act
This Act is the Supervised Injecting Place Trial Act 1999.
2 Dictionary
The dictionary at the end of this Act is part of this Act.
Note 1 The dictionary at the end of this Act defines certain terms used in this
Act.
Note 2 A definition in the dictionary applies to the entire Act unless the
definition, or another provision of the Act, provides otherwise or the
contrary intention otherwise appears (see Legislation Act, s 155 and
s 156 (1)).
3 Notes
A note included in this Act is explanatory and is not part of this Act.
Note See Legislation Act, s 127 (1), (4) and (5) for the legal status of notes.
4 Object
The object of this Act is to allow the temporary operation of a
supervised injecting place, for the purpose of an independently
evaluated scientific trial of—
(a) the public health benefits and risks of such places; and
(b) other matters relating to the operation of a supervised injecting
place.
Operation of facility Part 2
Section 5
R10
01/09/16
Supervised Injecting Place Trial Act 1999
Effective: 01/09/16
page 3
Authorised by the ACT Parliamentary Counsel—also accessible at www.legislation.act.gov.au
Part 2 Operation of facility
5 Declaration of facility
(1) The Minister may, in writing, declare a place to be the facility for
this Act.
(2) The Minister may declare a place to be the facility only if—
(a) the Minister is satisfied the place is a hygienic environment
suitable for use—
(i) to give drug-dependent people access to clean equipment
to allow such a person to administer a substance to
himself or herself at the place; and
(ii) to provide for the safe disposal of the equipment; and
(b) a law enforcement protocol has been approved under section 7
and published as required by section 8; and
(c) an internal management protocol has been approved under
section 9; and
(d) approved criteria for the scientific trial have been presented to
the Legislative Assembly as required by section 10; and
(e) the place to be declared as the facility is one that has been
recommended by the advisory committee.
(3) A declaration is a notifiable instrument.
Note A notifiable instrument must be notified under the Legislation Act 2001.
(4) The Minister must give additional public notice of a declaration
under subsection (3).
Note Public notice means notice on an ACT government website or in a daily
newspaper circulating in the ACT (see Legislation Act, dict, pt 1). The
requirement in s (4) is in addition to the requirement for notification on
the legislation register as a notifiable instrument.
Part 2 Operation of facility
Section 6
page 4 Supervised Injecting Place Trial Act 1999
Effective: 01/09/16
R10
01/09/16
Authorised by the ACT Parliamentary Counsel—also accessible at www.legislation.act.gov.au
6 Declaration of operators
(1) The Minister may, after consultation with the advisory committee,
in writing, declare a person to be the operator of the facility.
(2) The Minister shall not declare a non-government organisation to be
the operator other than in accordance with a recommendation of the
advisory committee.
(3) A declaration under this section is a notifiable instrument.
Note A notifiable instrument must be notified under the Legislation Act 2001.
7 Law enforcement protocol
(1) The Minister may, after consultation with the advisory committee,
by instrument approve a protocol that deals with—
(a) the detection, investigation and prosecution of offences by a
person who self-administers a substance at the facility; and
(b) anything else necessary or convenient to be dealt with to give
effect to the object of this Act;
as the law enforcement protocol for this Act.
(2) The Minister must ensure that a protocol is approved under this
section that will allow the facility to function in accordance with the
object of this Act.
(3) The Minister must not approve a protocol that has the effect of
exempting a member of the staff of the facility from the operation of
a law in relation to the possession, use or dealing in substances.
8 Publication of law enforcement protocol
(1) The Minister must give public notice of the effect of an instrument
made under section 7, as soon as practicable after the instrument is
made.
Note Public notice means notice on an ACT government website or in a daily
newspaper circulating in the ACT (see Legislation Act, dict, pt 1).
Operation of facility Part 2
Section 9
R10
01/09/16
Supervised Injecting Place Trial Act 1999
Effective: 01/09/16
page 5
Authorised by the ACT Parliamentary Counsel—also accessible at www.legislation.act.gov.au
(2) The notice must state the places where a copy of the law
enforcement protocol may be bought or, at any reasonable time,
inspected.
(3) The Minister must ensure that—
(a) copies of the law enforcement protocol may be bought at each
place stated for that purpose in the notice; and
(b) a copy of the law enforcement protocol is, at any reasonable
time, available for inspection at each place stated for that
purpose in the notice.
9 Approval of internal management protocol
(1) The Minister may, by instrument, approve a protocol relating to the
facility as the internal management protocol for this Act.
(2) An operator shall manage the facility in accordance with the internal
management protocol.
(3) Before making an instrument under subsection (1), the Minister
must be satisfied that the following requirements will be met:
(a) the facility must be under the supervision of a supervisor;
(b) the supervisor must have general oversight of the clinical
operations of the facility and responsibility for ensuring that
adequate clinical procedures are used in the facility;
(c) each member of staff of the facility who directly supervises
injection of substances at the facility must be a doctor or a
nurse;
(d) each member of staff of the facility who issues equipment at
the facility for use in injection of substances at the facility must
hold an approval under the Public Health Act 1997, part 3A
(Supply of syringes);
Part 2 Operation of facility
Section 10
page 6 Supervised Injecting Place Trial Act 1999
Effective: 01/09/16
R10
01/09/16
Authorised by the ACT Parliamentary Counsel—also accessible at www.legislation.act.gov.au
(e) the facility must contain, or provide satisfactory access to—
(i) primary health care services (including medical
consultation and medical assessment services); and
(ii) drug and alcohol counselling services; and
(iii) health education services; and
(iv) drug and alcohol detoxification and rehabilitation
services; and
(v) services for testing for blood borne diseases;
(f) the health and safety of staff and users of the facility must be
protected, having regard to the design of, and services provided
by, the facility;
(g) any recommendations of the advisory committee concerning
the operation of the facility must be given effect;
(h) any regulations concerning the operation of the facility must be
complied with.
10 Criteria for assessing facility
(1) The Minister must consult the advisory committee on the
appropriate criteria, and must attempt to agree with the committee
on a set of criteria.
(2) If a set of criteria is agreed, the Minister must approve them.
(3) If agreement is not possible—
(a) the advisory committee must set out its preferred criteria
(alternative criteria); and
(b) the Minister must approve a set of criteria and a statement of
the reasons why they are approved instead of the alternative
criteria (Minister’s reasons).
Operation of facility Part 2
Section 11
R10
01/09/16
Supervised Injecting Place Trial Act 1999
Effective: 01/09/16
page 7
Authorised by the ACT Parliamentary Counsel—also accessible at www.legislation.act.gov.au
(4) The Minister must present a copy of the approved criteria, together
with any alternative criteria and Minister’s reasons, to the
Legislative Assembly within 3 sitting days after the approval.
(5) In this section:
criteria means criteria by which the scientific trial of the effects of
giving drug-dependent people a place to self-administer a substance
is to be assessed.
11 Exemption of staff and other persons from certain
criminal proceedings
(1) This section applies to a person who is or has been—
(a) a Minister or public employee; or
(b) a member of the staff of the facility; or
(c) the owner or occupier of the premises where the facility is
situated.
(2) A proceeding for a criminal offence (including an offence against
the Criminal Code, section 717 (Accessory after the fact)) does not
lie against a person to whom this section applies in relation to an
act—
(a) done in good faith by the person in the person’s capacity as a
person to whom this section applies; and
(b) that consists of participating, or being in any other way
concerned, in the establishment of the facility or in its
operation as a supervised injecting place; and
(c) done in accordance with the requirements (if any) prescribed
under the regulations.
Part 2 Operation of facility
Section 12
page 8 Supervised Injecting Place Trial Act 1999
Effective: 01/09/16
R10
01/09/16
Authorised by the ACT Parliamentary Counsel—also accessible at www.legislation.act.gov.au
12 Exemption of persons from certain civil proceedings
A civil proceeding does not lie against the Territory or anyone else
in relation to the death of, or any loss or injury sustained by,
someone (the affected person) caused by, or arising out of—
(a) the self-administration by the affected person of a substance at
the facility; or
(b) anything else done by the affected person, whether or not at the
facility, in relation to the self-administration.
13 Directions to DPP
(1) The Attorney-General must give such directions to the DPP under
the Director of Public Prosecutions Act 1990, section 20 (1) as are
necessary to ensure that drug-dependent people are not deterred by
fear of prosecution for an offence from making use of the facility in
accordance with the object of this Act.
(2) The directions for subsection (1) must include, but are not limited
to, a direction stating circumstances in which the DPP is restrained
from prosecuting a person who administers a substance to himself or
herself at the facility for an offence against—
(a) the Drugs of Dependence Act 1989, section 169 (Possessing
drugs of dependence) or section 171 (Possessing prohibited
substances); or
(b) the Medicines, Poisons and Therapeutic Goods Act 2008,
section 36 (Possessing certain declared substances) or
section 37 (Administering certain declared substances).
14 Things not permitted by Act
This Act does not permit—
(a) the members of the staff of the facility to sell or possess or use
a substance in the facility; or
Operation of facility Part 2
Section 15
R10
01/09/16
Supervised Injecting Place Trial Act 1999
Effective: 01/09/16
page 9
Authorised by the ACT Parliamentary Counsel—also accessible at www.legislation.act.gov.au
(b) a drug-dependent person to sell or supply a substance in the
facility; or
(c) a drug-dependent person to possess in the facility more than
0.5g of a substance; or
(d) a drug-dependent person to possess a substance outside the
facility.
15 Provision of injecting equipment at facility
Despite any other provision of this Act or of another Territory law,
it is lawful for a member of the staff of the facility to provide, at the
facility, sterile equipment to another person for use by the other
person, at the facility, to self-administer a substance, if the other
person—
(a) agrees to return the equipment after use for safe disposal; and
(b) unless the member of the staff knows, or reasonably believes,
that the other person has previously administered a substance
to himself or herself—the other person has been offered
counselling or rehabilitation or medical services at the facility.
16 Provision of information about facility
Despite any other provision of this Act or of another Territory law,
it is lawful for a person to give, for this Act, information about the
operation of the facility to—
(a) the Legislative Assembly or a committee of the Assembly; or
(b) the Minister or a public employee acting in the course of his or
her duties on behalf of a Minister; or
(c) the advisory committee; or
(d) a person appointed in writing by the Minister to review the
effectiveness of the facility in meeting the relevant objectives
of this Act.
Part 2 Operation of facility
Section 17
page 10 Supervised Injecting Place Trial Act 1999
Effective: 01/09/16
R10
01/09/16
Authorised by the ACT Parliamentary Counsel—also accessible at www.legislation.act.gov.au
17 Excluding persons from facility
(1) The operator or the person for the time being in charge of the
facility may exclude a person from the facility by telling the person
orally that he or she is excluded under this Act for a stated period
that is not longer than 3 days.
(2) The operator or the person for the time being in charge of the
facility may exclude a person from the facility by telling the person
in writing that he or she is excluded under this Act for a stated
period, giving brief reasons for the exclusion.
(3) A person who has been told under subsection (1) or (2) that he or
she is excluded—
(a) must leave the facility immediately; and
(b) must not enter the facility during the stated period.
Maximum penalty (subsection (3)): 10 penalty units.
Advisory committee Part 3
Section 18
R10
01/09/16
Supervised Injecting Place Trial Act 1999
Effective: 01/09/16
page 11
Authorised by the ACT Parliamentary Counsel—also accessible at www.legislation.act.gov.au
Part 3 Advisory committee
18 Advisory committee
An advisory committee, to be called the Supervised Drug Injection
Trial Advisory Committee, is established.
19 Committee’s functions
The functions of the advisory committee are—
(a) to make written recommendations to the Minister about the
matters mentioned in section 29 (1) (Minister must consult
committee); and
(b) to exercise other functions given to the advisory committee by
this Act or another Territory law.
Note 1 A provision of a law that gives an entity (including a person) a function
also gives the entity powers necessary and convenient to exercise the
function (see Legislation Act, s 196 and dict, pt 1, def entity).
Note 2 A reference to an Act includes a reference to the statutory instruments
made or in force under the Act, including regulations (see Legislation
Act, s 104).
20 Constitution
(1) Subject to subsection (2), the advisory committee consists of
members made up as follows:
(a) the director-general;
(b) 1 person nominated by, and representing, each of the following
persons or bodies:
(i) the Australian Federal Police;
(ii) the director of public prosecutions;
(iii) the legal aid office;
(iv) the ambulance service;
Part 3 Advisory committee
Section 20
page 12 Supervised Injecting Place Trial Act 1999
Effective: 01/09/16
R10
01/09/16
Authorised by the ACT Parliamentary Counsel—also accessible at www.legislation.act.gov.au
(v) the Australian Institute of Criminology;
(vi) the Australian Medical Association;
(vii) the Canberra City Heart Business Association;
(viii) the Women’s Information Resources and Education on
Drugs and Dependency (WIREDD);
(ix) an association representing residents of an area where the
facility is, or is to be, located;
(x) Assisting Drug Dependents Inc;
(xi) National Centre for Epidemiology and Health;
(xii) Canberra Injectors Network;
(xiii) Australian Intravenous League;
(xiv) Alcohol and other Drugs Council of Australia;
(xv) the Winnunga Nimmityjah Aboriginal Health Service;
(xvi) the Youth Coalition of the ACT.
(2) The regulations may reduce or extend the membership of the
advisory committee.
(3) Each member of the advisory committee is appointed by the
Minister for a term of not longer than 3 years.
Note 1 For the making of appointments (including acting appointments), see
Legislation Act, pt 19.3.
Note 2 A person may be reappointed to a position if the person is eligible to be
appointed to the position (see Legislation Act, s 208 and dict, pt 1, def
appoint).
(4) A member holds office on the terms (if any) in relation to matters
not provided for by this Act that are stated in the instrument of
appointment.
Advisory committee Part 3
Section 21
R10
01/09/16
Supervised Injecting Place Trial Act 1999
Effective: 01/09/16
page 13
Authorised by the ACT Parliamentary Counsel—also accessible at www.legislation.act.gov.au
21 Chairperson and deputy chairperson
The Minister must appoint—
(a) a member of the advisory committee to be chairperson of the
advisory committee; and
(b) a member of the advisory committee to be deputy chairperson
of the advisory committee.
22 Ending of appointments
(1) The Minister may end the appointment of a member for
misbehaviour or physical or mental incapacity.
(2) The Minister must end the appointment of a member if the
member—
(a) becomes bankrupt or personally insolvent; or
(b) is absent for 3 consecutive meetings without leave; or
(c) is convicted in Australia or elsewhere of an offence punishable
by imprisonment for 1 year or longer.
Note A person’s appointment also ends if the person resigns (see Legislation
Act, s 210).
24 Convening meetings
(1) The chairperson, or if the chairperson cannot do so, the deputy
chairperson, must call such meetings of the advisory committee—
(a) as the chairperson or the deputy chairperson considers
necessary for the efficient performance of its functions; or
(b) as the Minister directs, by written notice given to the
chairperson or the deputy chairperson.
(2) The chairperson must call a meeting of the advisory committee if
asked by 3 members.
Part 3 Advisory committee
Section 25
page 14 Supervised Injecting Place Trial Act 1999
Effective: 01/09/16
R10
01/09/16
Authorised by the ACT Parliamentary Counsel—also accessible at www.legislation.act.gov.au
25 Leave of absence
The advisory committee may grant leave of absence (either before,
or at the earliest practicable time after, the absence occurs) to a
member.
26 Procedure
(1) The chairperson presides at a meeting of the advisory committee
when he or she is present.
(2) If the chairperson is not present, the deputy chairperson presides.
(3) If the chairperson and the deputy chairperson are both absent from a
meeting, the members present must elect a member present to
preside.
(4) The member presiding at a meeting may give directions in relation
to the procedure to be followed for the meeting.
(5) The member presiding at a meeting has a deliberative vote and, if
there is an equality of votes, a casting vote.
(6) The advisory committee must keep minutes of its proceedings.
(7) A meeting of the advisory committee may be called by telephone,
television or any other device which permits instantaneous audio
communication, with or without instantaneous visual
communication.
27 Quorum
At a meeting of the advisory committee, a majority of the members
for the time being of the advisory committee is a quorum.
28 Administration
The advisory committee may make arrangements with the
director-general for the provision of administrative or secretarial
services to the advisory committee.
Consultation with committee Part 4
Section 29
R10
01/09/16
Supervised Injecting Place Trial Act 1999
Effective: 01/09/16
page 15
Authorised by the ACT Parliamentary Counsel—also accessible at www.legislation.act.gov.au
Part 4 Consultation with committee
29 Minister must consult committee
(1) The Minister must consult the advisory committee about—
(a) any place to be declared to be the facility; and
(b) the operation of the facility (including the hours of operation);
and
(c) the conditions of access to the facility; and
(d) the terms on which people under 18 years old may attend the
facility; and
(e) the way in which, and the criteria by which, the effectiveness
of the operation of the facility may be evaluated.
(2) If the Minister decides not to give effect to a recommendation of the
advisory committee about a matter mentioned in subsection (1), the
Minister must—
(a) give a written statement of the reasons to the chairperson
within 14 days after making the decision; and
(b) present a copy of the statement to the Legislative Assembly,
within 3 sitting days after making the decision.
30 Criteria for deciding place for facility
In deciding whether to recommend a place to the Minister as the
facility, the advisory committee must have regard to—
(a) the cost of setting up and maintaining the facility at the place;
and
(b) the capacity to maintain the place in a hygienic condition; and
Part 4 Consultation with committee
Section 31
page 16 Supervised Injecting Place Trial Act 1999
Effective: 01/09/16
R10
01/09/16
Authorised by the ACT Parliamentary Counsel—also accessible at www.legislation.act.gov.au
(c) the capacity of the place to meet the objective of giving
drug-dependent people using the place access to counselling,
medical treatment, detoxification and other health promotion
services; and
(d) the means of safe disposal of injecting equipment after use.
31 Review of the operation of scientific trial
(1) The advisory committee must, as soon as practicable after the end of
each 6 months following the date of effect of the declaration of the
facility, give the Minister a report on—
(a) the operation of the facility during the 6 months; and
(b) the views of the advisory committee about the scientific trial
during the 6 months.
(2) The advisory committee must, before the expiry of this Act—
(a) arrange an assessment of the scientific trial against the criteria
approved under section 10; and
(b) give to the Minister a report containing the assessment together
with a recommendation either that the scientific trial continue
for a stated time, or that it cease.
(3) The Minister must present a copy of each report to the Legislative
Assembly within 6 sitting days after receiving the report.
Miscellaneous Part 5
Section 32
R10
01/09/16
Supervised Injecting Place Trial Act 1999
Effective: 01/09/16
page 17
Authorised by the ACT Parliamentary Counsel—also accessible at www.legislation.act.gov.au
Part 5 Miscellaneous
32 Regulation-making power
The Executive may make regulations for this Act.
Note Regulations must be notified, and presented to the Legislative
Assembly, under the Legislation Act 2001.
33 Expiry of Act
This Act expires 2 years after the day when the first declaration is
made under section 5.
Dictionary
page 18 Supervised Injecting Place Trial Act 1999
Effective: 01/09/16
R10
01/09/16
Authorised by the ACT Parliamentary Counsel—also accessible at www.legislation.act.gov.au
Dictionary
(see s 2)
Note 1 The Legislation Act contains definitions and other provisions relevant to
this Act.
Note 2 For example, the Legislation Act, dict, pt 1, defines the following terms:
• ambulance service
• Attorney-General
• bankrupt or personally insolvent
• director-general (see s 163)
• DPP
• Executive
• Legislative Assembly
• Minister (see s 162)
• notifiable instrument (see s 10)
• penalty unit (see s 133)
• public servant
• regulations.
advisory committee means the advisory committee established by
section 18.
chairperson means the chairperson of the advisory committee.
deputy chairperson means the deputy chairperson of the advisory
committee.
drug-dependent person—see the Medicines, Poisons and
Therapeutic Goods Act 2008, dictionary.
facility means the place that is declared under section 5 to be the
facility.
internal management protocol means a protocol approved under
section 9.
law enforcement protocol means a protocol approved under
section 8.
Dictionary
R10
01/09/16
Supervised Injecting Place Trial Act 1999
Effective: 01/09/16
page 19
Authorised by the ACT Parliamentary Counsel—also accessible at www.legislation.act.gov.au
operator, of the facility, means a person who is declared under
section 5 to be the operator of the facility.
staff, of the facility, includes the following persons:
(a) the operator of the facility;
(b) a manager of the facility;
(c) a person engaged by the operator or manager of the facility to
provide services at the facility, whether under a contract of
employment or otherwise;
(d) a person engaged by the operator or manager of the facility to
provide voluntary assistance at the facility.
substance means a controlled medicine, or prohibited substance,
within the meaning of the Medicines, Poisons and Therapeutic
Goods Act 2008.
supervised injecting place means a place that provides—
(a) a supervised and hygienic environment for the self-
administration of substances by drug-dependent people; and
(b) access to clean equipment for such self-administration, and
safe facilities for disposing of the equipment; and
(c) an opportunity for users of the facility to be referred to
counselling, medical treatment, detoxification and similar
services.
Endnotes
1 About the endnotes
page 20 Supervised Injecting Place Trial Act 1999
Effective: 01/09/16
R10
01/09/16
Authorised by the ACT Parliamentary Counsel—also accessible at www.legislation.act.gov.au
Endnotes
1 About the endnotes
Amending and modifying laws are annotated in the legislation history and the
amendment history. Current modifications are not included in the republished
law but are set out in the endnotes.
Not all editorial amendments made under the Legislation Act 2001, part 11.3 are
annotated in the amendment history. Full details of any amendments can be
obtained from the Parliamentary Counsel’s Office.
Uncommenced amending laws are not included in the republished law. The
details of these laws are underlined in the legislation history. Uncommenced
expiries are underlined in the legislation history and amendment history.
If all the provisions of the law have been renumbered, a table of renumbered
provisions gives details of previous and current numbering.
The endnotes also include a table of earlier republications.
2 Abbreviation key
A = Act NI = Notifiable instrument
AF = Approved form o = order
am = amended om = omitted/repealed
amdt = amendment ord = ordinance
AR = Assembly resolution orig = original
ch = chapter par = paragraph/subparagraph
CN = Commencement notice pres = present
def = definition prev = previous
DI = Disallowable instrument (prev...) = previously
dict = dictionary pt = part
disallowed = disallowed by the Legislative r = rule/subrule
Assembly reloc = relocated
div = division renum = renumbered
exp = expires/expired R[X] = Republication No
Gaz = gazette RI = reissue
hdg = heading s = section/subsection
IA = Interpretation Act 1967 sch = schedule
ins = inserted/added sdiv = subdivision
LA = Legislation Act 2001 SL = Subordinate law
LR = legislation register sub = substituted
LRA = Legislation (Republication) Act 1996 underlining = whole or part not commenced
mod = modified/modification or to be expired
Endnotes
Legislation history 3
R10
01/09/16
Supervised Injecting Place Trial Act 1999
Effective: 01/09/16
page 21
Authorised by the ACT Parliamentary Counsel—also accessible at www.legislation.act.gov.au
3 Legislation history
Supervised Injecting Place Trial Act 1999 A1999-90
notified 23 December 1999 (Gaz 1999 No S65)
commenced 23 December 1999 (s 2)
Note Act expires 2 years after the day when the first declaration is
made under s 5 (see s 33)
as amended by
Supervised Injecting Place Trial Amendment Act 2000 A2000-39
notified 12 July 2000 (Gaz 2000 No S36)
commenced 12 July 2000 (s 2)
Legislation (Consequential Amendments) Act 2001 A2001-44 pt 373
notified 26 July 2001 (Gaz 2001 No 30)
s 1, s 2 commenced 26 July 2001 (IA s 10B)
pt 373 commenced 12 September 2001 (s 2 and see Gaz 2001
No S65)
Statute Law Amendment Act 2003 (No 2) A2003-56 sch 3 pt 3.26
notified LR 5 December 2003
s 1, s 2 commenced 5 December 2003 (LA s 75 (1))
sch 3 pt 3.26 commenced 19 December 2003 (s 2)
Emergencies Act 2004 A2004-28 pt 3.23
notified LR 29 June 2004
s 1, s 2 commenced 29 June 2004 (LA s 75 (1))
pt 3.23 commenced 1 July 2004 (s 2 (1) and CN2004-11)
Medicines, Poisons and Therapeutic Goods Act 2008 A2008-26
sch 2 pt 2.22
notified LR 14 August 2008
s 1, s 2 commenced 14 August 2008 (LA s 75 (1))
sch 2 pt 2.22 commenced 14 February 2009 (s 2 and LA s 79)
Statute Law Amendment Act 2008 A2008-28 sch 3 pt 3.55
notified LR 12 August 2008
s 1, s 2 commenced 12 August 2008 (LA s 75 (1))
sch 3 pt 3.55 commenced 26 August 2008 (s 2)
Endnotes
3 Legislation history
page 22 Supervised Injecting Place Trial Act 1999
Effective: 01/09/16
R10
01/09/16
Authorised by the ACT Parliamentary Counsel—also accessible at www.legislation.act.gov.au
Statute Law Amendment Act 2009 (No 2) A2009-49 sch 3 pt 3.71
notified LR 26 November 2009
s 1, s 2 commenced 26 November 2009 (LA s 75 (1))
sch 3 pt 3.71 commenced 17 December 2009 (s 2)
Administrative (One ACT Public Service Miscellaneous Amendments)
Act 2011 A2011-22 sch 1 pt 1.143
notified LR 30 June 2011
s 1, s 2 commenced 30 June 2011 (LA s 75 (1))
sch 1 pt 1.143 commenced 1 July 2011 (s 2 (1))
Red Tape Reduction Legislation Amendment Act 2015 A2015-33
sch 1 pt 1.62
notified LR 30 September 2015
s 1, s 2 commenced 30 September 2015 (LA s 75 (1))
sch 1 pt 1.62 commenced 14 October 2015 (s 2)
Public Sector Management Amendment Act 2016 A2016-52 sch 1
pt 1.58
notified LR 25 August 2016
s 1, s 2 commenced 25 August 2016 (LA s 75 (1))
sch 1 pt 1.58 commenced 1 September 2016 (s 2)
Endnotes
Amendment history 4
R10
01/09/16
Supervised Injecting Place Trial Act 1999
Effective: 01/09/16
page 23
Authorised by the ACT Parliamentary Counsel—also accessible at www.legislation.act.gov.au
4 Amendment history
Long title
long title sub A2008-26 amdt 2.152
Dictionary
s 2 om R1 LRA
ins A2003-56 amdt 3.246
am A2008-26 amdt 2.153
Notes
s 3 defs reloc to dict A2003-56 amdt 3.245
sub A2003-56 amdt 3.246
Declaration of facility
s 5 am A2000-39 s 4; A2001-44 amdts 1.3948-1.3950;
A2003-56 amdt 3.247; A2008-26 amdt 2.161; A2015-33
amdt 1.217
Declaration of operators
s 6 am A2001-44 amdt 1.3951, amdt 1.3952
Publication of law enforcement protocol
s 8 am A2015-33 amdt 1.218
Approval of internal management protocol
s 9 am A2008-26 amdt 2.154
Criteria for assessing facility
s 10 am A2008-26 amdt 2.161
Exemption of staff and other persons from certain criminal proceedings
s 11 am A2008-28 amdt 3.165
Directions to DPP
s 13 am A2008-26 amdt 2.155, amdt 2.161
Things not permitted by Act
s 14 am A2008-26 amdt 2.156
Committee’s functions
s 19 am A2001-44 amdt 1.3953, amdt 1.3954
sub A2003-56 amdt 3.248
Constitution
s 20 am A2003-56 amdts 3.249-3.251; A2011-22 amdt 1.409
Chairperson and deputy chairperson
s 21 am A2003-56 amdt 3.252
Ending of appointments
s 22 sub A2003-56 amdt 3.253
am A2008-28 amdt 3.166; A2009-49 amdt 3.184
Endnotes
5 Earlier republications
page 24 Supervised Injecting Place Trial Act 1999
Effective: 01/09/16
R10
01/09/16
Authorised by the ACT Parliamentary Counsel—also accessible at www.legislation.act.gov.au
Resignation
s 23 om A2003-56 amdt 3.253
Administration
s 28 am A2011-22 amdt 1.409
Minister must consult committee
s 29 am A2003-56 amdt 3.254
Criteria for deciding place for facility
s 30 am A2008-26 amdt 2.161
Regulation-making power
s 32 am A2001-44 amdt 1.3955
Dictionary
dict ins A2003-56 amdt 3.255
am A2004-28 amdt 3.66; A2009-49 amdt 3.185; A2011-22
amdt 1.410; A2016-52 amdt 1.156
def advisory committee reloc from s 3 A2003-56 amdt 3.245
def chairperson reloc from s 3 A2003-56 amdt 3.245
def deputy chairperson reloc from s 3 A2003-56 amdt 3.245
def drug dependent person reloc from s 3 A2003-56
amdt 3.245
om A2008-26 amdt 2.157
def drug-dependent person ins A2008-26 amdt 2.157
def drug of dependence reloc from s 3 A2003-56 amdt 3.245
om A2008-26 amdt 2.158
def Drugs of Dependence Act reloc from s 3 A2003-56
amdt 3.245
om A2008-26 amdt 2.158
def facility reloc from s 3 A2003-56 amdt 3.245
def internal management protocol reloc from s 3 A2003-56
amdt 3.245
def law enforcement protocol reloc from s 3 A2003-56
amdt 3.245
def newspaper reloc from s 3 A2003-56 amdt 3.245
om A2015-33 amdt 1.219
def operator reloc from s 3 A2003-56 amdt 3.245
def prohibited substance reloc from s 3 A2003-56
amdt 3.245
om A2008-26 amdt 2.159
def staff reloc from s 3 A2003-56 amdt 3.245
def substance reloc from s 3 A2003-56 amdt 3.245
sub A2008-26 amdt 2.160
def supervised injecting place reloc from s 3 A2003-56
amdt 3.245
am A2008-26 amdt 2.161